We are live on ! Find out more
TNGX icon

Tango Therapeutics
TNGX

100 hedge funds and large institutions have $1,000M invested in Tango Therapeutics in 2023 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 33 increasing their positions, 26 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

341% more capital invested

Capital invested by funds: $227M → $1,000M (+$773M)

200% more funds holding in top 10

Funds holding in top 10: 2 → 6 (+4)

100% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 11

27% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 26

12% more funds holding

Funds holding: 89 → 100 (+11)

10.02% more ownership

Funds ownership: 77.28% → 87.3% (+10%)

Holders
100
Holders Change
+11
Holders Change %
+12.36%
% of All Funds
1.59%
Holding in Top 10
6
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+200%
% of All Funds
0.1%
New
22
Increased
33
Reduced
26
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NI
Nextech Invest
Switzerland
+$33.7M
2
EC
EcoR1 Capital
California
+$28.5M
3
PA
Perceptive Advisors
New York
+$14.8M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$7.79M
5
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
+$5.92M

Top Sellers

Rank Fund Capital Flow
1
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$1.07M
2
Millennium Management
Millennium Management
New York
-$1.03M
3
Citadel Advisors
Citadel Advisors
Florida
-$548K
4
BlackRock
BlackRock
New York
-$396K
5
Man Group
Man Group
United Kingdom
-$277K
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$4.14M +$1.51M +247,234 +206%
AAA
27
Affinity Asset Advisors
New York
$3.94M +$2.13M +350,000 New
WP
28
Woodline Partners
California
$2.81M -$83.2K -13,645 -5%
EI
29
EAM Investors
California
$2.36M +$1.28M +209,401 New
TCM
30
Tang Capital Management
California
$2.25M – – –
Morgan Stanley
31
Morgan Stanley
New York
$2.18M +$848K +139,130 +257%
N
32
Nuveen
North Carolina
$2.04M +$62.5K +10,246 +6%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$1.74M +$81.8K +13,418 +9%
Jacobs Levy Equity Management
34
Jacobs Levy Equity Management
New Jersey
$1.62M -$1.07M -175,295 -55%
PHP
35
Parkman Healthcare Partners
Connecticut
$1.53M +$829K +135,920 New
Two Sigma Investments
36
Two Sigma Investments
New York
$1.49M +$430K +70,531 +115%
Goldman Sachs
37
Goldman Sachs
New York
$1.29M +$148K +24,293 +27%
Swiss National Bank
38
Swiss National Bank
Switzerland
$1.12M -$95.7K -15,700 -14%
Barclays
39
Barclays
United Kingdom
$990K +$193K +31,618 +56%
Wellington Management Group
40
Wellington Management Group
Massachusetts
$909K +$492K +80,747 New
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$786K -$5.24K -859 -1%
CS
42
Credit Suisse
Switzerland
$706K +$62.1K +10,176 +19%
Dimensional Fund Advisors
43
Dimensional Fund Advisors
Texas
$675K +$365K +59,914 New
DekaBank Deutsche Girozentrale
44
DekaBank Deutsche Girozentrale
Germany
$653K +$366K +60,000 New
State of Wisconsin Investment Board
45
State of Wisconsin Investment Board
Wisconsin
$632K +$342K +56,094 New
Bank of America
46
Bank of America
North Carolina
$585K -$79.8K -13,079 -20%
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$566K -$67.8K -11,117 -18%
FAM
48
Fred Alger Management
New York
$533K +$289K +47,337 New
JP Morgan Chase
49
JP Morgan Chase
New York
$532K +$46.5K +7,624 +19%
SSA
50
Schonfeld Strategic Advisors
New York
$465K +$252K +41,294 New
1
2
3 4 5

TNGX Hedge Fund Activity: Q3 2023 in Review

100 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Tango Therapeutics (TNGX) for Q3 2023, worth a combined $1,000M — up 341% from $227M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new TNGX positions and 11 closed out — a net gain of 11 holders — while 33 added to existing stakes and 26 trimmed.

The largest buyer was Nextech Invest, opening a new position worth an estimated $33.7M. The largest seller was Jacobs Levy Equity Management, cutting an estimated $1.07M.

  • 100 institutional investors held Tango Therapeutics (TNGX) as of Q3 2023, up from 89 in Q2 2023.
  • Funds reported $1,000M of Tango Therapeutics stock for Q3 2023, up 341% quarter-over-quarter.
  • 22 funds opened new Tango Therapeutics positions in Q3 2023 and 11 closed out, a net change of +11 holders.
  • The largest Tango Therapeutics buyer in Q3 2023 was Nextech Invest, an estimated $33.7M added.
  • The largest Tango Therapeutics seller in Q3 2023 was Jacobs Levy Equity Management, an estimated $1.07M sold.

Based on aggregated 13F filings for Q3 2023.